Spectral AI posts investor deck showing 2024E rev ~$28M (+56% YoY) and 85% burn trial enrollment

Spectral AI, Inc.

H1 2024 revenue $13.8M; FY 2023 revenue $18M, FY 2024 expected ~$28M.
Cash position $6.9M at June 30, 2024; $10M committed equity facility secured.
Burn pivotal trial 85%+ enrolled (160 goal); enrollment completion expected Sept 2024.
DeepView platform targets burn ($3.7B TAM) and diabetic foot ulcer ($11B TAM) markets.
Joined Russell Microcap Index; 26 issued and 38 pending patents.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.